While IL-6-receptor antagonists are expected to improve depression and mood in general in patients with a mood disorder, given that they counteract the neuroinflammation that IL-6 is likely to induce [41], they are still to be tested in patients with major depressive disorder. Here, IL6 is linked to major depressive disorder.